Medical treatment of pituitary adenomas: effects on tumor growth.
Liuzzi
A
A
Chiodini
P G
PG
Dallabonzana
D
D
Oppizzi
G
G
Verde
G G
GG
D000236:Adenoma / Q000188:drug therapy* / Q000473:pathology; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001971:Bromocriptine / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D004334:Drug Administration Schedule; D004873:Ergolines / Q000031:analogs & derivatives / Q000627:therapeutic use; D013006:Growth Hormone / Q000378:metabolism; D007980:Levodopa / Q000627:therapeutic use; D008090:Lisuride / Q000627:therapeutic use; D008711:Metergoline / Q000627:therapeutic use; D008784:Methysergide / Q000627:therapeutic use; D010479:Pergolide; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011388:Prolactin / Q000378:metabolism; D014057:Tomography, X-Ray Computed
D004873:Ergolines; D004088:Dihydroergotoxine; D008711:Metergoline; D010479:Pergolide; D001971:Bromocriptine; D007980:Levodopa; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone; D008090:Lisuride; C031875:lergotrile; C031649:mesulergine; D004298:Dopamine; D008784:Methysergide